血浆血管性血友病因子抗原水平对老年急性心肌梗死 患者长期预后的预测价值
2025-07-01陈珍进金晓青祁安宁韩崇旭
中图分类号:R541.4 文献标志码:A DOI:10.11958/20250518
Abstract:ObjectiveTo investigate the predictive valueofplasmavon Willbrand factor(VWF)antigen levels forthe long-termprognosisofpatientswithacutemyocardialinfarction(AMI).MethodsAtotalof15Oelderlypatientsdiagnosed with AMI were selectedand treated with percutaneous coronary intervention (PCI)at admission.The plasma VWFantigen levelof the patients was detected within24 hoursafterPCI.Patientswerefollowedupfor12 monthsandweredivided into the major adverse cardiac events (MACE) group and the non-MACE group according to the occurrence of MACE.The risk factors for MACE inAMI patients within12 monthswere analyzed.The prognostic valueof VWFantigen level in AMI patientswereevaluated.Theoptimal cut-off valueof plasma VWFantigen level was determined byreceiveroperating characteristic (ROC)curve.Patients were groups according to theoptimal cut-offvalue.Kaplan-Meiercurve was drawn to compare theoccurrenceof MACE inpatientswith diffrentplasmaVWFantigen levels.ResultsAmong the15Oobserved patients,7patients werelosttofolow-up,andeventually143 patients were included.In143 patients there were53 patients (204号 (37.1%) in the MACE group and 90 cases (63.9% ) in the non-MACE group. The age, B-type natriuretic peptide (BNP), Ddimerand VWFantigenlevels weresignificantlyhigherintheMACE groupthanthose inthenon-MACE group.Theresults of the Cox proportional hazards model showed that age increase ( HR=1.085 , 95%CI : 1.014-1.160), increased plasma VWF antigen level(HR=1.030,95%CI: 1.017-1.045)and increasedBNP(HR=1.016,95%CI: 1.004-1.027)were risk factors for elderly patients in the MACE grouponeyear after surgery.The maximumapproximately Youden index of plasma VWF antigen level for predicting MACE was O.616,the optimal cut-off value was 162.5μg/L ,the sensitivity was 84.9% and the specificity was 76.7% .The results of survival analysis showed that the average time to MACE in the group with plasma VWF antigen ⩾162.5μg/L was shorter than that in the group with plasmaVWF antigen lt;162.5μg/L (7.7 months us. 11.6 months, Log-rank χ2 =63.060, Plt;0.001 ).ConclusionThe increased plasma VWF antigen is an independent risk factor for AMI and can be used as a predictor of long-term prognosis in patients with AMI.
KeyWords:myocardial infarction;risk factor; von Willebrand factor; major adverse cardiac events
冠状动脉粥样硬化性心脏病是常见的心血管疾病,患病率和死亡率在我国呈不断上升的趋势[1-2]。急性心肌梗死(acutemyocardialinfarction,AMI)是在冠状动脉粥样硬化的基础上出现冠状动脉闭塞,致使血流中断,使部分心肌因严重的持久性缺血而发生局部坏死,也是心血管疾病最严重、最凶险的表现形式[3]。动脉血栓形成涉及多种机制,包括血小板、内皮细胞、内皮下基质和纤维蛋白原、血管性血友病因子(vonWillebrandfactor,VWF)等其他止血因子[4]。有证据表明,VWF在高剪切应力条件下通过与血小板表面受体相结合,促进其在血流快速的部位(如动脉狭窄或破裂斑块)附着并聚集,是动脉血栓形成的关键介导因子[5-6]。目前,针对VWF与AMI预后的研究以回顾性研究为主,仅能证明VWF水平与AMI预后的关系,但无法验证VWF能否成为AMI患者预后的预测因子[7-8]。因此,本研究旨在通过前瞻性研究探讨血浆VWF水平对老年AMI患者预后的预测价值。
1对象与方法
1.1研究对象选取我院于2022年1月—2023年7月诊断为AMI的患者共计150例。纳入标准:(1)年龄 gt;65 岁。(2)符合《急性ST段抬高型心肌梗死诊断和治疗指南(2019)》[9]标准明确诊断为AMI。(3)入院后行经皮冠状动脉介入治疗(percutaneouscoronaryintervention,PCI)。排除标准:(1)有严重感染、血液病、恶性肿瘤、自身免疫性疾病、血栓性疾病。(2)既往有凝血功能障碍史。(3)近期使用影响血小板功能的激素或其他药物。患者人院后签署知情同意书即视为纳入随访周期,出院后每隔1个月进行随访,为期12个月。本研究为前瞻性队列研究,已通过我院伦理委员会审核(编号:LHRY-2022A004),患者均签署知情同意书。……
